CN103055263B - External use plaster for treating breast hyperplasia - Google Patents
External use plaster for treating breast hyperplasia Download PDFInfo
- Publication number
- CN103055263B CN103055263B CN201310006173.XA CN201310006173A CN103055263B CN 103055263 B CN103055263 B CN 103055263B CN 201310006173 A CN201310006173 A CN 201310006173A CN 103055263 B CN103055263 B CN 103055263B
- Authority
- CN
- China
- Prior art keywords
- parts
- plaster
- add
- mix
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention provides an external use plaster for treating the breast hyperplasia. The main components of the plaster comprise Vaccaria segetalis, myrrh, Boswellia carteri, Chinese angelica, safflower, dragon's blood, borneol, Fructus Toosendan, Rhizoma Curcumae and the like, so the plaster has the lactation promoting, stagnation eliminating, blood circulation promoting and stasis dissolving functions. The plaster which is a medicine is different from previous schemes for simply treating the breast hyperplasia, is used through adopting an acupoint plastering method, and has the advantages of multilevel and multi-targeting, yin and yang balance, system adjustment, simultaneous treatment of principal and subordinate symptoms, unique treatment method, and curative effect reliability.
Description
Technical field
The present invention relates to a kind of external plaster for the treatment of cyclomastopathy.
Background technology
Breast disease is women's commonly encountered diseases, frequently-occurring disease, and it is difficult to control for a long time, and sickness rate is up to 80%, and the sickness rate of cyclomastopathy has reached the more than 60% of the women of child-bearing age.In recent years, breast disease is in peak period, and canceration rate is very high, current research according to Chinese traditional Chinese medical science breast disease study on prevention center epidemiology statistics is found, female mammary gland cancer morbidity has increased by 39% in recent years, and age of onset has shifted to an earlier date 10 years old, gradually in rejuvenation, breast carcinoma is leapt to the first by several years ago the 5th in the ranking list of female tumor, becomes the No.1 killer of women's health.The patient who often encounters many cyclomastopathy in clinical is for this reason weighed down with anxieties, thinks that cyclomastopathy is also incurable disease, controls badly, does not remove root, cyclomastopathy really one easily examine, refractory, the easy disease of recurrence.At present to the treatment of primary disease mostly adopt hormone medicine, the method treatment such as have an operation, but DeGrain.
Summary of the invention
The object of this invention is to provide a kind of external plaster for the treatment of cyclomastopathy, this plaster curative effect is high, and expense is low, easy to use simple and direct, has no side effect, and does not recur after more.
The present invention treats the external plaster of cyclomastopathy and is made up by weight of following bulk drugs:
80~110 parts of Semen Vaccariae, 50~75 parts of Myrrhas, 50~75 parts of Olibanums, 60~80 parts of Radix Angelicae Sinensis, 60~80 parts, Flos Carthami, 40~55 parts of Sanguis Draxonis, 65~90 parts of Fructus Toosendans, 75~95 parts of Rhizoma Curcumae, 30~50 parts of Cornu Cervi Degelatinatums, 50~70 parts, Pericarpium Citri Reticulatae Viride, 60~80 parts of Rhizoma Bolbostematiss, 60~80 parts of Radix Phytolaccaes, 20~40 parts of Borneolum Syntheticums, 10~20 parts of laurocaprams, 150~250 parts of refined honeys, 100~250 parts of lanolines, 70~150 parts of propylene glycol.
The preparation method of this plaster is as follows:
Semen Vaccariae, Radix Angelicae Sinensis, Flos Carthami, Sanguis Draxonis, Rhizoma Curcumae, Pericarpium Citri Reticulatae Viride, Rhizoma Bolbostematis, Borneolum Syntheticum powder are broken into fine powder (100 mesh sieve), mix, for subsequent use; Myrrha, Olibanum, Fructus Toosendan, Cornu Cervi Degelatinatum, Radix Phytolaccae add the decocting of 8 times of amounts to boil 2 hours, filter, and medicinal residues add 6 times of water gagings to decoct 1.5 hours, filter, and merging filtrate, is concentrated into relative density 1.20~1.25(60 ℃) clear paste; After refined honey, lanoline, propylene glycol heating melting, constantly stir, add laurocapram to continue stirring and evenly mixing, in the time that temperature is down to 45~55 ℃, add above-mentioned clear paste to stir, mix; Add above-mentioned fine powder, stir, mix, cream core processed, and be placed in sticker, to obtain final product.
The present invention adopts root, stem, leaf flower, fruit, the seed of Chinese herbal medicine, through cleaning, and the techniques such as oven dry, under defined terms, Chinese herbal medicine be ground into respectively to fine powder and be extracted into extractum by Chinese medicine preparation technology, mixing and form by proportioning blending, this emplastrum, easy to use, blood pressure lowering in proper order, stable curative effect, thorough treatment, without any side effects, the main outer cyclomastopathy that is used for the treatment of.
Feature of the present invention
1, tcm characteristic: external treatment of Chinese medicine is, under theory of Chinese medical science determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs instructs, viscera, meridians, QI and blood are carried out to integrally-regulated process.Again to make medicine and physical agent directly act on quickly diseased region, by the process that skin permeates, mucosa absorption, acupoint stimulation etc. produce curative effect.Chinese medicine external medicine direct effect diseased region skin.Transdermal effect by medicine reaches high drug level at diseased region, can make up some deficiency of endo-medicine, reaching circulation of qi promoting, invigorate blood circulation, blood stasis dispelling, eliminating stagnation, thereby effectively remove symptom, and have letter, just, effect, honest and clean, the feature that has no side effect.
2, medicine directly imposes on affected part, and the application of transdermal technology has also increased the Transdermal absorption of medicine, and these are all the reasons that this plaster treatment cyclomastopathy condition of disease obtains satisfied curative effect.Transdermal absorption, medicine directly infiltrates focus deep skin tissue.Avoid the loss of medication amount and the poisoning to human viscera organ.Use its external application, penetration power is strong, can make local organization relax, unfold, and improves blood circulation, strengthens cell viability, thereby reaches rapidly the object of blood circulation promoting and blood stasis dispelling, lactogenesis eliminating stagnation, anti-inflammatory analgesic.Its external can improve blood circulation, strengthens cell viability, and the regeneration capacity of fortifying fibre and blood capillary promotes tissue regeneration, thereby reaches the object of detumescence, softening the hard mass, eliminating stagnation.
3, product is through a large amount of clinical verifications, and it is to epiderm skin tissue, subcutaneous tissue not damaged, and nonirritant, has no side effect.Sum up clinical experience for many years and gains in depth of comprehension and create out the cyclomastopathy plaster therapy of simple and direct practicability and effectiveness, regulation and control equilibrium between yin and yang, until basic rehabilitation hold stable for a long time; Thoroughly radical cure, does not need Long-term taking medicine, when the bioactive molecule in Gene regulation and plant in medicine enters after human body, activates and regulate disorderly hormonal system, makes it be tending towards normal secretion.Above done clinical observation on the therapeutic effect result shows, adopts plaster external ruling by law to treat cyclomastopathy, have short treating period, instant effect, curative effect high, have no side effect, the advantage such as no pain, convenience, satisfactory effect, patient is also easy to acceptance.
Be below to adopt plaster treatment cyclomastopathy 55 examples, obtained comparatively satisfied curative effect.Now be reported as follows.
1. clinical data
1.1 physical data
Cyclomastopathy patient 55 examples, all meet cyclomastopathy diagnostic criteria; 23~54 years old age, average 32.5 years old; The course of disease 2~15 years, average 8 years.Clinical manifestation bilateral breast hypertrophy 18 examples (32.7%), one-sided cyclomastopathy 33 examples (67.3%), mastalgia 53 examples (96.4%).
1.2 diagnostic criteria
(1) there is strip lump in breast, how to be primary symptom with periodicity distending pain of the breast; (2) palpation has streak lump, can promote; (3) prompting of galactophore scanning analyzer is A type or Type B blood vessel II~III degree ghost.
2. Therapeutic Method
2.1 efficacy assessment standard
Cure: pain and enclosed mass all disappear completely, and drug withdrawal is not recurred for 3 months; Effective: lump maximum gauge dwindles more than 1/2, and mastalgia alleviates; Effective: lump maximum gauge dwindles less than more than 1/2, and mastalgia alleviates; Invalid: lump does not dwindle or increases on the contrary hardening person, or simple mastalgia is alleviated and lump does not dwindle.
2.2 Therapeutic Method
55 routine patients all adopt strapping treatment, when use, plaster are spread on to affected part, change medicine every day one time, and 15~20 days is a course for the treatment of, the other drug of stopping using during treatment, and after 2 courses for the treatment of of patient's medication, drug withdrawal check in 3 months.When medication, note observing untoward reaction a situation arises simultaneously.
3. therapeutic outcome
In 55 examples, cure 45 examples, wherein treat 1 the courses for the treatment of 23 example, treat 2 the courses for the treatment of 22 example; Effective 6 examples; Effective 2 examples; Invalid 2 examples.Total effective rate 96.4%, does not find obvious adverse reaction during medication.
4. discuss
Plaster is by the through focus of the subcutaneous infiltration of liniment, and acceleration blood circulation, progressively softens the lump of hypertrophy, decomposes, absorbs, thereby reaches the object for the treatment of both the principal and secondary aspects of a disease.Through clinical practice, its treatment cyclomastopathy total effective rate 96.4%, does not find untoward reaction.
Effect of the present invention
External treatment is an important component part in Chinese medicine, with Chinese medicine percutaneous skin, acupuncture points on the human body, face nine orifices osmotic absorption and reach therapeutic purposes, have letter, just, honest and clean, the feature such as test, without the toxic and side effects such as gastrointestinal reaction and hepatorenal damage, show good prospect for treatment primary disease, significant for the primary prevention of breast carcinoma.The unique distinction of plaster shows: the one, and by arterial channel, the 2nd, by hydration, the 3rd, by Action of Surfactant, the 4th, by the facilitation of aromatic herbs.External therapy of Chinese herb indirect action is except dispenser, also has auxiliary warm stimulation, chemical stimulation and mechanical-physical to stimulate, and to accelerate blood circulation, promotes infiltration, absorption and the propagation of medicine and strengthens systemic effect.The external application of Chinese medicine, in acupuncture points on the human body, can, by the approach relevant to internal organs through cave, act on each system in body, and play the Accommodation of multisystem, many organs, too many levels.
Accompanying drawing explanation
Fig. 1 is the production technological process of plaster.
The specific embodiment
Embodiment 1 presses column weight amount weighting raw materials (unit: g)
Semen Vaccariae 100g, Myrrha 60g, Olibanum 60g, Radix Angelicae Sinensis 70g, Flos Carthami 70g, Sanguis Draxonis 50g, Fructus Toosendan 70g, Rhizoma Curcumae 80g, Cornu Cervi Degelatinatum 40g, Pericarpium Citri Reticulatae Viride 60g, Rhizoma Bolbostematis 70g, Radix Phytolaccae 70g, Borneolum Syntheticum 25g, laurocapram 15g, refined honey 220g, lanoline 120g, propylene glycol 80g.
Embodiment 2 presses column weight amount weighting raw materials (unit: g)
Semen Vaccariae 80g, Myrrha 55g, Olibanum 55g, Radix Angelicae Sinensis 75g, Flos Carthami 75g, Sanguis Draxonis 45g, Fructus Toosendan 80g, Rhizoma Curcumae 90g, Cornu Cervi Degelatinatum 35g, Pericarpium Citri Reticulatae Viride 55g, Rhizoma Bolbostematis 75g, Radix Phytolaccae 65g, Borneolum Syntheticum 30g, laurocapram 15g, refined honey 220g, lanoline 120g, propylene glycol 80g.
Embodiment 3 presses column weight amount weighting raw materials (unit: g)
Semen Vaccariae 95g, Myrrha 70g, Olibanum 70g, Radix Angelicae Sinensis 60g, Flos Carthami 65g, Sanguis Draxonis 55g, Fructus Toosendan 75g, Rhizoma Curcumae 85g, Cornu Cervi Degelatinatum 45g, Pericarpium Citri Reticulatae Viride 55g, Rhizoma Bolbostematis 65g, Radix Phytolaccae 75g, Borneolum Syntheticum 35g, laurocapram 15g, refined honey 220g, lanoline 120g, propylene glycol 80g.
The preparation method of above embodiment is:
In prescription, each taste Chinese crude drug is according to the clean system of regulation under Chinese Pharmacopoeia and this kind item of drug standard, the preparation method of plaster is: Semen Vaccariae, Radix Angelicae Sinensis, Flos Carthami, Sanguis Draxonis, Rhizoma Curcumae, Pericarpium Citri Reticulatae Viride, Rhizoma Bolbostematis, Borneolum Syntheticum powder are broken into fine powder (100 mesh sieve), mix, for subsequent use; Myrrha, Olibanum, Fructus Toosendan, Cornu Cervi Degelatinatum, Radix Phytolaccae add the decocting of 8 times of amounts to boil 2 hours, filter, and medicinal residues add 6 times of water gagings to decoct 1.5 hours, filter, and merging filtrate, is concentrated into relative density 1.20~1.25(60 ℃) clear paste; After refined honey, lanoline, propylene glycol heating and melting, constantly stir, add laurocapram to continue stirring and evenly mixing, in the time that temperature is down to 45~55 ℃, add above-mentioned clear paste to stir, mix; Add above-mentioned fine powder, stir, mix, cream core processed, and be placed in sticker, to obtain final product.
Using method: local skin is affixed on breast after cleaning.Within one to two day, change once.Points for attention: skin allergy person be cautious use of.
Claims (1)
1. treat an external plaster for cyclomastopathy, it is characterized in that being made by weight by following bulk drugs: 80~110 parts of Semen Vaccariae, 50~75 parts of Myrrhas, 50~75 parts of Olibanums, 60~80 parts of Radix Angelicae Sinensis, 60~80 parts, Flos Carthami, 40~55 parts of Sanguis Draxonis, 65~90 parts of Fructus Toosendans, 75~95 parts of Rhizoma Curcumae, 30~50 parts of Cornu Cervi Degelatinatums, 50~70 parts, Pericarpium Citri Reticulatae Viride, 60~80 parts of Rhizoma Bolbostematiss, 60~80 parts of Radix Phytolaccaes, 20~40 parts of Borneolum Syntheticums, 10~20 parts of laurocaprams, 150~250 parts of refined honeys, 100~250 parts of lanolines, 70~150 parts of propylene glycol;
The preparation method of above-mentioned plaster is: Semen Vaccariae, Radix Angelicae Sinensis, Flos Carthami, Sanguis Draxonis, Rhizoma Curcumae, Pericarpium Citri Reticulatae Viride, Rhizoma Bolbostematis, Borneolum Syntheticum powder is broken into fine powder, crosses 100 mesh sieves, mix, and for subsequent use; Myrrha, Olibanum, Fructus Toosendan, Cornu Cervi Degelatinatum, Radix Phytolaccae add the decocting of 8 times of amounts to boil 2 hours, filter, and medicinal residues add 6 times of water gagings to decoct 1.5 hours, filter merging filtrate, the clear paste that while being concentrated into 60 ℃, relative density is 1.20~1.25; After refined honey, lanoline, propylene glycol heating and melting, constantly stir, add laurocapram to continue stirring and evenly mixing, in the time that temperature is down to 45~55 ℃, add above-mentioned clear paste to stir, mix; Add above-mentioned fine powder, stir, mix, cream core processed, and be placed in sticker, to obtain final product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310006173.XA CN103055263B (en) | 2012-02-27 | 2013-01-08 | External use plaster for treating breast hyperplasia |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210045913.6 | 2012-02-27 | ||
CN2012100459136A CN102579977A (en) | 2012-02-27 | 2012-02-27 | External plaster for treating hyperplasia of mammary glands |
CN201310006173.XA CN103055263B (en) | 2012-02-27 | 2013-01-08 | External use plaster for treating breast hyperplasia |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103055263A CN103055263A (en) | 2013-04-24 |
CN103055263B true CN103055263B (en) | 2014-05-14 |
Family
ID=46469578
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012100459136A Pending CN102579977A (en) | 2012-02-27 | 2012-02-27 | External plaster for treating hyperplasia of mammary glands |
CN201310006173.XA Active CN103055263B (en) | 2012-02-27 | 2013-01-08 | External use plaster for treating breast hyperplasia |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012100459136A Pending CN102579977A (en) | 2012-02-27 | 2012-02-27 | External plaster for treating hyperplasia of mammary glands |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN102579977A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104586716A (en) * | 2013-10-31 | 2015-05-06 | 广州熹美生物科技有限公司 | Breast nursing cream |
CN106620525A (en) * | 2016-12-22 | 2017-05-10 | 苏祖荣 | Traditional Chinese medicine preparation for treating hyperplasia of mammary glands and preparation method |
CN112138106A (en) * | 2019-06-27 | 2020-12-29 | 河南省天施叶桂医药科技有限公司 | Method for preparing Chinese medicinal honey acupoint plaster |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101116738A (en) * | 2006-08-01 | 2008-02-06 | 青岛市市立医院 | Chinese traditional medicine for treating mammary gland hyperplasia and method for preparing the same |
CN101264266A (en) * | 2008-04-15 | 2008-09-17 | 尹伟 | Externally-applied paste for treating gland hyperplasia and preparation thereof |
CN101502580A (en) * | 2009-03-20 | 2009-08-12 | 汪世龙 | External-use medicament for treating tinea manus and pedis |
CN101564521A (en) * | 2009-05-20 | 2009-10-28 | 石振刚 | External plaster for treating hyperplasia of mammary glands |
CN102274450A (en) * | 2010-06-09 | 2011-12-14 | 买建修 | Breast pain syndrome dispersing paste |
-
2012
- 2012-02-27 CN CN2012100459136A patent/CN102579977A/en active Pending
-
2013
- 2013-01-08 CN CN201310006173.XA patent/CN103055263B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101116738A (en) * | 2006-08-01 | 2008-02-06 | 青岛市市立医院 | Chinese traditional medicine for treating mammary gland hyperplasia and method for preparing the same |
CN101264266A (en) * | 2008-04-15 | 2008-09-17 | 尹伟 | Externally-applied paste for treating gland hyperplasia and preparation thereof |
CN101502580A (en) * | 2009-03-20 | 2009-08-12 | 汪世龙 | External-use medicament for treating tinea manus and pedis |
CN101564521A (en) * | 2009-05-20 | 2009-10-28 | 石振刚 | External plaster for treating hyperplasia of mammary glands |
CN102274450A (en) * | 2010-06-09 | 2011-12-14 | 买建修 | Breast pain syndrome dispersing paste |
Also Published As
Publication number | Publication date |
---|---|
CN103055263A (en) | 2013-04-24 |
CN102579977A (en) | 2012-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103071128B (en) | Externally-applied plaster for curing dysmenorrhea | |
CN101810685B (en) | Chinese medicinal composition for treating gonitis and preparation method thereof | |
CN103330660B (en) | Skin-care health-care massage cream for waist and legs and preparation method thereof | |
CN103055263B (en) | External use plaster for treating breast hyperplasia | |
CN104984316A (en) | Medicine for treating female cold in uterus | |
CN103977092B (en) | A kind of pharmaceutical composition for the treatment of myocardial infarction, cerebral infarction | |
CN102784213A (en) | Externally applied fumigation-washing traditional Chinese medicine for treating talalgia and calcaneal hyperplasia | |
CN103393943B (en) | Traditional Chinese medicine composition for treating sequela of cerebral infarction | |
CN102671180B (en) | Medicine for treating rheumatic lumbago and preparation method thereof | |
CN102038889B (en) | Traditional Chinese medicament for treating rheumatic heart disease | |
CN105535380A (en) | Medicine bathing bag and preparing method thereof | |
CN106552039A (en) | It is a kind of to cure root bone pain footbath with traditional Chinese medicines health care prescription | |
CN104117018A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
CN104147382A (en) | Plaster for treating lumbago-leg pain | |
CN105687961A (en) | Preparation method of granule for treating coronary artery atherosclerosis | |
CN108653704A (en) | A kind of lotion and preparation method thereof with anti-inflammatory analgetic function | |
CN107998367A (en) | A kind of dispersing swelling and dissipating binds stasis-dispelling and pain-killing plaster | |
CN105497190A (en) | Traditional Chinese medicine fumigation pill and production technology thereof | |
CN101244174B (en) | Medicine for treating angiitis and preparation thereof | |
CN105497185A (en) | Chinese medicinal ointment for treating fracture | |
CN104524454A (en) | Tinospora sinensis pain-relieving tincture | |
CN104491051A (en) | Traditional Chinese medicine preparation for recuperative medical care of chronic low back pains | |
CN105853843A (en) | Pharmaceutical composition for clinical pediatric wound care and preparation method of pharmaceutical composition for clinical pediatric wound care | |
CN105168973A (en) | Traditional Chinese medicine for treating cervical spondylosis and lumbar spondylosis | |
CN104491334A (en) | Traditional Chinese medicine fumigation lotion for treating pain after hemorrhoids operation and nursing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |